Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Lifecare AS ( (DE:LFC0) ) has shared an announcement.
Lifecare ASA is a medical sensor developer focused on next-generation continuous glucose monitoring systems, using osmotic pressure–based sensing to detect a broad range of analytes in humans and pets. The company targets the advanced diagnostics and monitoring segment, aiming to commercialise miniaturised sensor technology for continuous health tracking.
Lifecare ASA is centralising its operations as it moves from technology development to product realisation and production, establishing manufacturing in Bergen, Norway and consolidating chemistry-related activities in its Bristol, U.K. subsidiary. As part of this strategic shift, the company will liquidate Lifecare Germany GmbH and transfer relevant activities to Norway and the U.K., a move expected to streamline the group’s structure, cut operating costs and accelerate the transition to scalable production and commercialisation.
The wind-down of the German unit will occur through a structured, solvent liquidation process in line with German legal requirements and will unfold over the coming months, including a statutory 12‑month creditor period. While the restructuring will incur one‑off expenses related to employees and contractual settlements, management expects a material reduction in ongoing costs and improved efficiency, with further updates promised as the process advances.
More about Lifecare AS
Lifecare ASA is a medical sensor company developing technology for sensing and monitoring various body analytes, with a primary focus on next-generation continuous glucose monitoring systems. The company’s osmotic pressure–based sensor technology is designed for use in humans and pets and can be adapted to detect a wide range of analytes and molecules, positioning Lifecare within the advanced medical diagnostics and monitoring market.
Average Trading Volume: 4,976,736
Current Market Cap: NOK74.32M
For an in-depth examination of LFC0 stock, go to TipRanks’ Overview page.